Engineering Extracellular Vesicles Derived from 3D Cultivation of BMSCs Enriched with HGF Ameliorate Sepsis‐Induced Lung Epithelial Barrier Damage
Advanced Science · 2025
DOI: 10.1002/advs.202500637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yong Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Sepsis, Hepatocyte Growth Factor, Mesenchymal Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Key Supported Disciplines by Shanghai Municipal Health Commission, Natural Science Foundation of Shanghai Grant.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a critical condition with high mortality, often leading to acute lung injury (ALI) due to uncontrolled inflammatory responses and alveolar epithelial damage. Extracellular vesicles (EVs), particularly mesenchymal stem cell‐derived EVs, have shown therapeutic potential in sepsis‐related organ dysfunction by transferring RNAs and proteins. However, their clinical use is limited by low efficacy and yield. To address this, 3D‐cultured MSCs (3D‐MSCs) are generated using MicroTissues 3D Petri Dish. These 3D‐MSCs demonstrate improved protection and proliferation of MLE‐12 cells in vitro. Mechanistic studies are conducted to explore the enhanced protective effects of 3D‐MSCs derived EVs (3D‐EVs) in a septic‐ALI model. Proteomic and molecular analyses of 3D‐EVs revealed that they are enriched in hepatocyte growth factor (HGF). HGF helps maintain the barrier function of damaged alveolar epithelium through the PI3K‐AKT signaling pathway. Overall, 3D‐EVs effectively ameliorate sepsis‐induced ALI and enhance prognosis by enriching and delivering HGF, suggesting that their application represents a promising treatment strategy for septic ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.
- Shanghai Institute of Acupuncture and Anesthesia, Shanghai, 200433, China.
- Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
ORCID-Profile: Xin Lv
Förderung
- National Natural Science Foundation of China
- Project of Key Supported Disciplines by Shanghai Municipal Health Commission
- Natural Science Foundation of Shanghai Grant
- Development Fund for the Department of Anesthesiology, Shanghai Pulmonary Hospital
- Zhejiang Provincial Natural Scientific Foundation
Zitieren
APA
Chen, Y., Lin, F., Zhang, T., Xiao, Z., Chen, Y., Hua, D., Wang, Y., Wei, J., Jin, T., & Lv, X. (2025). Engineering Extracellular Vesicles Derived from 3D Cultivation of BMSCs Enriched with HGF Ameliorate Sepsis‐Induced Lung Epithelial Barrier Damage. Advanced Science. https://doi.org/10.1002/advs.202500637
Vancouver
Chen Y, Lin F, Zhang T, Xiao Z, Chen Y, Hua D, et al. Engineering Extracellular Vesicles Derived from 3D Cultivation of BMSCs Enriched with HGF Ameliorate Sepsis‐Induced Lung Epithelial Barrier Damage. Advanced Science. 2025. doi:10.1002/advs.202500637
BibTeX
@article{Chen2025,
author = {Chen, Yong and Lin, Feihong and Zhang, Tong and Xiao, Zhuoran and Chen, Yuanli and Hua, Dongsheng and Wang, Yu and Wei, Juan and Jin, Tian and Lv, Xin},
title = {Engineering Extracellular Vesicles Derived from 3D Cultivation of BMSCs Enriched with HGF Ameliorate Sepsis‐Induced Lung Epithelial Barrier Damage},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500637}
}
EUVIMED